Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid

Hiroe SatoDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuoku, Niigata, Niigata 951-8510, Japan;Department of Rheumatology, Niigata Rheumatic Center, 1-2-8 Honcho, Shibata, Niigata 957-0054, JapanCorrespondence[email protected]

Satoshi ItoDepartment of Rheumatology, Niigata Rheumatic Center, 1-2-8 Honcho, Shibata, Niigata 957-0054, Japan

Shingo NagaiDepartment of ophthalmology, Shibata Hospital, 1-2-8 Honcho, Shibata, Niigata 957-0054, Japan

Akira MurasawaDepartment of Rheumatology, Niigata Rheumatic Center, 1-2-8 Honcho, Shibata, Niigata 957-0054, Japan

Yoko WadaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuoku, Niigata, Niigata 951-8510, Japan

Shuichi MurakamiDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuoku, Niigata, Niigata 951-8510, Japan

Takeshi KurodaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuoku, Niigata, Niigata 951-8510, Japan

Masaaki NakanoMedical Laboratory Science, School of Health Sciences, Faculty of Medicine Niigata University, 2-746 Asahimachi-Dori, Chuoku, Niigata, Niigata 951-8510, Japan

Ichiei NaritaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuoku, Niigata, Niigata 951-8510, Japan

show all

Abstract

A 36-year-old woman was diagnosed with systemic lupus erythematosus (SLE). Seven days after beginning glucocorticoid treatment, she developed reduced visual acuity, and atypical severe central serous chorioretinopathy (CSC) was confirmed. Since glucocorticoid use is an important risk factor for CSC, the PSL was reduced, tacrolimus was added, and the visual acuity improved rapidly. Reduction in glucocorticoid combined with the use of immunosuppressive agents is one option for preventing a deterioration in atypical severe CSC while still controlling SLE.

Keywords::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid

Information for

Open access

Opportunities

Help and information

Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature